What is your approach for, and in which situations would you use, an external boost in the management of gynecologic cancers?   

If an external boost of a gyn primary is necessitated because of the target size or extensive involvement of a critical structure how would you approach this? Are there potential pitfalls for which you would caution?



Answer from: Radiation Oncologist at Academic Institution